Peri-transplant TP53 molecular MRD as a prognostic biomarker of relapse in TP53-mutated AML/MDS undergoing allogeneic HCT
用户Lz2LyWF0h8HA
1个月前
60
10
已完结
1. 系统已在2026-07-05 00:56:33对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1038/s41408-026-01561-4
文献链接: https://www.nature.com/articles/s41408-026-01561-4
其他信息:
出版社: Springer Science and Business Media LLC
作者: Yeqian Zhao; Weijie Cao; Jimin Shi; Yiqiu Zheng; Yi Luo; Jian Yu; Lizhen Liu; Xiaoyu Lai; Huarui Fu; Congxiao Zhang; Yi Yu; Yishan Ye; Jiehan Liang; Xin Huang; Yang Cao; Wei Shi; Xiaoxia Hu; He Huang; Yanmin Zhao
全文下载地址: https://www.nature.com/articles/s41408-026-01561-4.pdf
